These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10805476)

  • 21. Casebook: proteinuria.
    de Zoysa JR; Harris KP
    Practitioner; 2003 Nov; 247(1652):860-2, 866, 870 passim. PubMed ID: 14640049
    [No Abstract]   [Full Text] [Related]  

  • 22. Reply to the letter from G. Smith. Angiotensin converting enzyme inhibitor (ACEI) and reflux nephropathy.
    Lama G; Salsano ME; Pedullà M; Grassia C; Ruocco G
    Pediatr Nephrol; 1999 Aug; 13(6):552. PubMed ID: 10452288
    [No Abstract]   [Full Text] [Related]  

  • 23. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is proteinuria reduction by angiotensin-converting enzyme inhibition enough to prove its role in renal protection in IgA nephropathy?
    Cattran DC
    J Am Soc Nephrol; 2007 Jun; 18(6):1633-4. PubMed ID: 17494880
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
    Renke M; Rutkowski P; Tylicki L; Zietkiewicz M; Larczyński W; Rutkowski B
    Przegl Lek; 2008; 65(6):312-4. PubMed ID: 18853664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How should renin-angiotensin system blockade be applied in chronic kidney disease for optimal renal protection?
    Zhang X; Hou FF
    Chin Med J (Engl); 2007 Feb; 120(3):243-5. PubMed ID: 17355830
    [No Abstract]   [Full Text] [Related]  

  • 28. [Kidney failure, proteinuria, and diabetic nephropathy].
    Collart F
    Rev Med Brux; 2003 Sep; 24(4):A257-62. PubMed ID: 14606290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
    Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
    Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Verapamil versus amlodipine in proteinuric non-diabetic nephropathies treated with trandolapril (VVANNTT study): design of a prospective randomized multicenter trial.
    Boero R; Rollino C; Massara C; Vagelli G; Gonella M; Berto IM; Bajardi P; Perosa P; Malcangi U; Giorgi MP; Ghezzi PM; Borzumati M; Baroni AM; Cogno C; Triolo G; Angelini D; Antonelli A; Quarello F
    J Nephrol; 2001; 14(1):15-8. PubMed ID: 11281338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of benazepril and valsartan alone or in combination on proteinuria in chronic glomerular disease].
    Zhang DY; Yang YL; Chen WD; Huang YY; Li LH; Wang YW; Zhu XJ; Xu HH; Yang LC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):762-3. PubMed ID: 18093443
    [No Abstract]   [Full Text] [Related]  

  • 32. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.
    Zaffanello M; Franchini M; Fanos V
    Pharmacotherapy; 2008 Jan; 28(1):125-30. PubMed ID: 18154482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases].
    Esnault V
    Nephrol Ther; 2006 May; 2 Suppl 3():S193-6. PubMed ID: 17370850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacogenetics of angiotensin system in non diabetic nephropathy].
    Coto E; Marín R; Alvarez V; Praga M; Fernández Andrade C; Arias M; Poveda R; Vallés M; Galcerán JM; Luño J; Rivera F; Campistol JM
    Nefrologia; 2005; 25(4):381-6. PubMed ID: 16231503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symposium: The kidney: therapeutic implications of ACE inhibition. July 17-18, 1987, San Diego. Proceedings.
    Am J Hypertens; 1988 Oct; 1(4 Pt 2):331S-422S. PubMed ID: 3190861
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of benazepril in chronic renal insufficiency.
    Curren CG
    N Engl J Med; 1996 Aug; 335(8):597; author reply 597. PubMed ID: 8684418
    [No Abstract]   [Full Text] [Related]  

  • 38. Is angiotensin-converting enzyme inhibitor appropriate for contrast-induced nephropathy? A meta-analysis about this field.
    Li X; Li T; Fu N; Hu Y; Cong H
    Int J Cardiol; 2012 Mar; 155(3):486-8. PubMed ID: 22264872
    [No Abstract]   [Full Text] [Related]  

  • 39. Proteinuria in chronic kidney disease in cats--prognostic marker or therapeutic target?
    Elliott J; Syme HM
    J Vet Intern Med; 2006; 20(5):1052-3. PubMed ID: 17063695
    [No Abstract]   [Full Text] [Related]  

  • 40. Obstructive nephropathy and the developing kidney: too little or too much angiotensin?
    Chevalier RL
    Kidney Int; 2004 Apr; 65(4):1517-8. PubMed ID: 15086496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.